Elsbeth M. Westerman

1.1k total citations
26 papers, 817 citations indexed

About

Elsbeth M. Westerman is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Emergency Medicine. According to data from OpenAlex, Elsbeth M. Westerman has authored 26 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Epidemiology and 4 papers in Emergency Medicine. Recurrent topics in Elsbeth M. Westerman's work include Inhalation and Respiratory Drug Delivery (7 papers), Cystic Fibrosis Research Advances (7 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Elsbeth M. Westerman is often cited by papers focused on Inhalation and Respiratory Drug Delivery (7 papers), Cystic Fibrosis Research Advances (7 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Elsbeth M. Westerman collaborates with scholars based in Netherlands, United States and Australia. Elsbeth M. Westerman's co-authors include Daan J. Touw, Harry Heijerman, Steven Conway, P.P.H. Le Brun, Henderik W. Frijlink, Arwen Sprij, Anne H. de Boer, Paul Hamberg, Boudewijn Klop and Marijke A. de Vries and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Elsbeth M. Westerman

23 papers receiving 789 citations

Peers

Countries citing papers authored by Elsbeth M. Westerman

Since Specialization

Citations

This map shows the geographic impact of Elsbeth M. Westerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsbeth M. Westerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsbeth M. Westerman more than expected).

Fields of papers citing papers by Elsbeth M. Westerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsbeth M. Westerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsbeth M. Westerman. The network helps show where Elsbeth M. Westerman may publish in the future.

Co-authorship network of co-authors of Elsbeth M. Westerman

This figure shows the co-authorship network connecting the top 25 collaborators of Elsbeth M. Westerman. A scholar is included among the top collaborators of Elsbeth M. Westerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsbeth M. Westerman. Elsbeth M. Westerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Particulate contamination in parenteral fluid from glass ampoules: compliance assessment and comparative analysis of needle types and ampoule-breaking strategies 2025 ·European Journal of Pharmaceutical Sciences ·(unknown), (unknown), Elsbeth M. Westerman, Jörn O. Streefkerk, Erik B. Wilms, Mirjam Crul, Eleonora L. Swart	0
2	Examination of Particulate Contamination in Parenteral Injections and Infusions Following Fluid Withdrawal Utilizing Conventional Needles and Filter Needles: Assessment of Compliance and Comparative Analysis 2024 ·Journal of Pharmaceutical Sciences ·(unknown), (unknown), Mirjam Crul, Erik B. Wilms, Eleonora L. Swart, Elsbeth M. Westerman	3
3	Tolerability and effectiveness of palbociclib in older women with metastatic breast cancer 2024 ·Breast Cancer Research and Treatment ·(unknown), Simon P. Mooijaart, Annelie Vulink, Danny Houtsma, Wendy M. van der Deure, Elsbeth M. Westerman, Hendrika M. Oosterkamp, (unknown), Frederiek van den Bos, Nienke A. de Glas, Johanneke E.A. Portielje	3
4	Sulpiride intoxication: Case report of a rare intoxication 2020 ·Basic & Clinical Pharmacology & Toxicology ·(unknown), (unknown), Erik B. Wilms, Peter Van de Vliet, Elsbeth M. Westerman	0
5	A Critical Note on Treatment of a Severe Diltiazem Intoxication: High‐Dose Calcium and Glucagon Infusions 2017 ·Basic & Clinical Pharmacology & Toxicology ·(unknown), Gijs van der Veen, (unknown), Elsbeth M. Westerman	3
6	[Hypervitaminosis D due to a dietary supplement]. 2016 ·PubMed ·(unknown), Elsbeth M. Westerman, (unknown)	2
7	Effect of a single dose vitamin D3 on postprandial arterial stiffness and inflammation in vitamin D deficient women 2016 ·The Journal of Clinical Endocrinology & Metabolism ·Marijke A. de Vries, (unknown), Gert‐Jan M. van de Geijn, Boudewijn Klop, (unknown), Lenneke Prinzen, Erwin Birnie, Elsbeth M. Westerman, Wouter W. de Herder, Manuel Castro Cabezas	12
8	Letter to the editor in response to the article “Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients” by Kivity S, Zafrir Y, Loebstein R, Pauzner R, Mouallem M, Mayan H, Autoimmun Rev. 2014 Nov.;13(11):1109–13 2016 ·Autoimmunity Reviews ·(unknown), Ethan den Boer, Elsbeth M. Westerman, Johanna M W Hazes, Róbert de Jonge	9
9	Glucose-dependent leukocyte activation in patients with type 2 diabetes mellitus, familial combined hyperlipidemia and healthy controls 2014 ·Metabolism ·Marijke A. de Vries, Arash Alipour, Boudewijn Klop, Gert‐Jan M. van de Geijn, (unknown), Tjin L. Njo, (unknown), (unknown), Anho Liem, Elsbeth M. Westerman, Wouter W. de Herder, Manuel Castro Cabezas	37
10	The postprandial situation as a pro-inflammatory condition 2014 ·Clínica e Investigación en Arteriosclerosis ·Marijke A. de Vries, Boudewijn Klop, Silvia A. Eskes, (unknown), (unknown), (unknown), (unknown), Elsbeth M. Westerman, Manuel Castro Cabezas	23
11	Postprandial Inflammation: Targeting Glucose and Lipids 2014 ·Advances in experimental medicine and biology ·Marijke A. de Vries, Boudewijn Klop, (unknown), Tjin L. Njo, Elsbeth M. Westerman, Manuel Castro Cabezas	44
12	Therapeutic Drug Monitoring of Aminoglycosides in Neonates 2009 ·Clinical Pharmacokinetics ·Daan J. Touw, Elsbeth M. Westerman, Arwen Sprij	79
13	Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus 2009 ·Journal of Cystic Fibrosis ·Harry Heijerman, Elsbeth M. Westerman, Steven Conway, Daan J. Touw	188
14	Aerosolization of Tobramycin (TOBI ^® ) with the PARI LC PLUS ^® Reusable Nebulizer: Which Compressor to Use? Comparison of the CR60 ^® to the PortaNeb ^® Compressor 2008 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Elsbeth M. Westerman, Anne H. de Boer, Daan J. Touw, P.P.H. Le Brun, Albert C. Roldaan, Henderik W. Frijlink, Harry Heijerman	16
15	Quetiapine in Overdosage 2006 ·Therapeutic Drug Monitoring ·Nicole Hunfeld, Elsbeth M. Westerman, (unknown), (unknown), Michel J. A. M. van Putten, Daan J. Touw	34
16	Dry powder inhalation of colistin sulphomethate in healthy volunteers: A pilot study 2006 ·International Journal of Pharmaceutics ·Elsbeth M. Westerman, Albertus H. de Boer, P.P.H. Le Brun, Daan J. Touw, Henderik W. Frijlink, Harry Heijerman	32
17	Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer®) for high powder doses 2006 ·European Journal of Pharmaceutical Sciences ·Anne H. de Boer, Paul Hagedoorn, Elsbeth M. Westerman, P.P.H. Le Brun, Harry Heijerman, Henderik W. Frijlink	64
18	Dry powder inhalation of colistin in cystic fibrosis patients: A single dose pilot study 2006 ·Journal of Cystic Fibrosis ·Elsbeth M. Westerman, Anne H. de Boer, P.P.H. Le Brun, Daan J. Touw, Albert C. Roldaan, Henderik W. Frijlink, Harry Heijerman	73
19	Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study 2004 ·Journal of Cystic Fibrosis ·Elsbeth M. Westerman, P.P.H. Le Brun, Daan J. Touw, Henderik W. Frijlink, Harry Heijerman	74
20	Epidemiology and Clinical Characteristics of Tularemia in Oklahoma, 1979 to 1985 1991 ·Southern Medical Journal ·(unknown), Elsbeth M. Westerman, Gregory R. Istre	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact